Key result
Hemagglutination-inhibition detects homologous response in ~96% of children infected with Coxsackie B virus.
Why the study?
Agglutination of human erythrocytes by Coxsackie B virus types and the use of hemagglutination-inhibition to detect antibody responses in infected children were investigated.
Observational (n=25)
Hemagglutination-inhibition is an effective procedure for detecting homologous antibody responses in children infected with Coxsackie B viruses.
Answers are grounded in this paper and cite their sources.
Supports HI test for pediatric Coxsackie B serology; leaves open prospective validation before clinical adoption.
Agglutination of human erythrocytes by Coxsackie B virus types 1 and 5 is reported. Optimum titers were obtained with a sedimentation temperature of 37†C and the erythrocytes of newborn infants. A hemagglutination–inhibition (HI) procedure employing Coxsackie B virus types 1, 3, and 5 was used to test paired sera from 25 children infected with Coxsackie B virus types 3. 4. and 5. A significant homologous response was detected in every case except one. A few heterologous responses occurred in children with pre–existing HI antibody to one or more of the 3 test antigens.
No takes yet. Share an insight, caveat, or question.
Rosen et al. (1961) conducted an observational in Coxsackie B virus infection (n=25). Hemagglutination-inhibition (HI) procedure was evaluated on Significant homologous response. A hemagglutination-inhibition procedure detected a significant homologous response in 24 of 25 children infected with Coxsackie B virus types 3, 4, and 5.
Synapse has enriched 10 related papers. Consider them for comparative context: